Le Lézard
Classified in: Health
Subject: SVY

Diabetic Food Market Analysis By Application (Confectionery, Ice Creams And Jellies, Dietary Beverages, Baked Products, And Dairy Products), By Regions (North America, Asia Pacific, Europe, Central & South America, MEA) And Segment Forecasts, 2014 - 2025


NEW YORK, Feb. 23, 2017 /PRNewswire/ -- The global diabetic food market is expected to reach USD 11.76 billion by 2025, according to a new report by Grand View Research, Inc. Rising demand for diabetic food in the medical sector is anticipated to fuel the market growth.

Rising health concerns and an uptrend in the occurrence of diabetes among youngsters, and health issues such as obesity, diabetes, and digestive disorders have prompted consumers to opt for such diabetic food solutions. Wide applications of diabetic food in healthcare sector including, insulin and medical food, are expected to positively the growth of the market over the forecast period of 2014 to 2025.

The diabetic food industry is governed by various regulations that cover the entire lifecycle ranging from production to end use. Diabetic products used in the healthcare industry need to strictly abide by the stringent U.S. FDA regulations. Health disorders are a result of unhealthy lifestyles such as long working hours, sedentary lifestyle, smoking, poor food habits and alcohol consumption and are anticipated to influence the industry growth over the forecast period.

Further key findings from the report suggest:

The global diabetic food demand was USD 7 billion in 2015 and is estimated to grow at a CAGR of 5.4% from 2016 to 2025

Demand in dairy application is estimated to exceed USD 3 billion by 2025, owing to its probiotic properties

Baked products application segment is estimated to grow at a CAGR of 5.5% over the forecast period owing to the large demand of sugar-free baked products by health conscious consumers

Product demand in Asia Pacific is expected to grow at a significant rate of 6.0% over the next nine years owing to the emerging economies and the growing investment in the medical foods sector

Diabetic food industry in North America is anticipated to exceed USD 4 billion by 2025, owing to the growing medical sector and imbalance in work life and unhealthy lifestyle

Companies such as Coca-Cola Company and PepsiCo Inc. offer raw materials including, dietary syrups, carbon dioxide, sweeteners, and juices, to various industries including, frozen foods, nutritional and functional foods, beverages, medical and processed foods.

Business expansions by companies, such as Mondel?z International to establish global research, development & quality (RDQ) network of the future, is anticipated to strengthen the market presence over the coming years
Read the full report: http://www.reportlinker.com/p04717551-summary/view-report.html

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com


__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

 

SOURCE Reportlinker


These press releases may also interest you

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...

at 17:21
Chemistree Technology Inc. (US OTC: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that the adjourned extraordinary meeting of the holders of the 10% senior unsecured convertible debentures of the Company (the "Debentures") was...

at 17:15
Summary Product: Counterfeit Viagra, 100 mg sildenafil tabletsIssue: Health products - Product safety, Unauthorized productWhat to do: Immediately stop using and safely dispose of this product. Consult your health care provider if you have taken this...

at 17:00
GBLT Corp. ("GBLT" or the "Company") announces that minority shareholders have approved the voluntary delisting (the "Delisting") of the common shares of the Company from the TSX Venture Exchange ("TSXV").  Approval for the delisting was received at...



News published on and distributed by: